In-Vitro Diagnostics Market
In-Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis By Application (Diabetes, Infectious Diseases, Cancer, Drug Testing, Autoimmune Diseases and Others), By Product (Instruments, Reagents and Software and Services), By Technology (Immunodiagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics and Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories and Others), Forecast Period (2026-2035)
Industry Overview
In-vitro diagnostics (IVD) market was valued at $108.3 billion in 2025 and is projected to reach $196.6 billion by 2035, growing at a CAGR of 5.7% during the forecast period (2026-2035). The market growth is driven by the rising prevalence of chronic and infectious diseases, technological advancements like molecular diagnostics and next-generation sequencing, and an aging population. Other key factors include the expansion of healthcare infrastructure, the growing demand for personalized medicine, and the increased use of point-of-care testing.
Market Dynamics
Rising Prevalence Of Chronic and Infectious Diseases
One of the strongest growth engines for the IVD market is the increasing incidence of both chronic non?communicable diseases (e.g., cardiovascular disease, diabetes, cancer) and persistent/re?emerging infectious diseases. According to a market report, “some of the key growth factors driving the market growth include the increasing prevalence of chronic and infectious diseases globally. For instance, as populations age and lifestyles shift (sedentary habits, poor diet, etc.), the burden of conditions such as diabetes and cancer rises—driving demand for diagnostic tests. At the same time, regions with high infectious?disease burden (including emerging economies) are expanding diagnostic testing. This dual disease burden creates a sustained and expanding need for IVD products—from reagents and consumables to instrumentation and services.
Technological Innovation And Expansion Of Point-of-Care Diagnostics
Another critical driver is technology advancement, particularly in the areas of molecular diagnostics, point?of?care (POC) testing, digital health integration, and decentralised diagnostics. For example, a report notes that the market growth is supported by advancements in diagnostic technologies and the shift toward value?based healthcare, emphasising early detection and preventive care. As healthcare systems shift from reactive to proactive and personalised care models, IVD players are developing faster, more sensitive, and more portable tests. These include rapid immunoassays, molecular panels, multiplex tests, and near?patient testing devices. The growth of POC also opens up testing outside traditional central labs (clinics, home settings, remote locations), which expands addressable markets, especially in underserved geographies.
Demographic Shifts, Rising Healthcare Spending & Emerging Market Expansion
A third driver is the broader demographic and economic context: ageing populations (which drive higher disease incidence and diagnostic demand), increasing healthcare expenditure globally, and growing healthcare infrastructure in emerging markets. For instance, a report states that the market is growing due to established infrastructure, healthcare expenditure, and an increasing prevalence of infectious diseases, cancer, and other disorders. Emerging regions (Asia?Pacific, Latin America, Middle East/Africa) are investing more in diagnostics, enabling greater access, which in turn boosts volumes and geographic reach. Furthermore, with more disposable income and greater awareness of preventive health in developing economies, diagnostic uptake is rising. This combination of demographic, economic, and infrastructure factors provides a broad platform for IVD market expansion.
Market Segmentation
- Based on the application, the market is segmented into diabetes, infectious diseases, cancer, drug testing, autoimmune diseases, and others.
- Based on the product, the market is segmented into instruments, reagents and software, and services.
- Based on the end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, and others.
Reagents Segment to Grow at a Considerable Market Share
Among all the segments in the global IVD market, the reagents segment under Product is projected to be the largest and lead the market over the forecast period. Reagents and consumables account for the majority of IVD revenues because they are essential for every diagnostic test and are frequently replenished, creating a recurring revenue stream for manufacturers. While instruments and software/services involve higher initial costs, reagents are used across multiple applications—such as diabetes monitoring, infectious disease detection, cancer diagnostics, and autoimmune disease testing—making them indispensable. The consistent demand, coupled with the increasing prevalence of chronic and infectious diseases worldwide, ensures that the reagents segment will maintain the highest market share. This dominance is reinforced by technological advances, including molecular and immunodiagnostic assays, which further increase the volume and variety of reagents required, solidifying this segment as the primary growth driver of the global IVD market.
Molecular Diagnostics: A Key Segment in Market Growth
Among all segments in the global IVD market, molecular diagnostics under the technology category stands out as the key growth driver over the forecast period. Molecular diagnostics leverage advanced techniques such as PCR, next-generation sequencing, and nucleic acid amplification to detect genetic, infectious, and oncological conditions with high sensitivity and specificity. The surge in demand for rapid and precise testing, particularly for infectious diseases like COVID?19, HIV, and hepatitis, has accelerated the adoption of molecular diagnostic tools globally. Furthermore, the increasing prevalence of cancer and genetic disorders has bolstered the need for personalized and precision medicine, where molecular diagnostics are indispensable for early detection, risk stratification, and treatment monitoring. Unlike traditional immunodiagnostics or hematology tests, molecular diagnostics enable clinicians to deliver targeted therapies, improve patient outcomes, and reduce healthcare costs through accurate, timely interventions.
In addition, technological advancements and miniaturization have made point-of-care molecular diagnostic devices more accessible, expanding their adoption in hospitals, clinics, and diagnostic laboratories. Regulatory support and rising awareness among healthcare providers about the clinical benefits of molecular diagnostics further contribute to its rapid growth. This segment is also attracting significant investments from leading players such as Roche, Abbott, Thermo Fisher Scientific, and Qiagen, who continue to innovate with multiplex panels, rapid molecular assays, and integrated platforms. Collectively, these factors position molecular diagnostics as the most dynamic and fastest-growing segment of the global IVD market, outpacing traditional applications such as diabetes testing and hematology in terms of growth momentum, adoption, and strategic importance across regions.
Regional Outlook
The global in-vitro diagnostics (IVD) market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
Market Players Outlook
The major companies operating in the global in-vitro diagnostics (IVD) market include BAE Systems plc, General Dynamics Corp., Northrop Grumman Corp., Olin Corp., Rheinmetall AG, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Developments
- In February 2025, Aiforia Technologies Plc obtained IVDR certification for its AI-assisted medical software, allowing it to introduce three CE-IVD-marked AI models for breast and prostate cancer diagnostics in the European market. The certification, granted by BSI Group, ensures compliance with the IVD Regulation 2017/746. The Aiforia® Breast Cancer HER2 AI model helps pathologists assess HER2 status in breast cancer samples, while the Aiforia® Prostate Cancer Gleason 4 Cribriform and Perineural Invasion AI models assist in detecting specific patterns in prostate tissue images. Both models are part of their respective Clinical Suites, which offer a user-friendly interface for digital pathology analysis, enhancing workflows and collaboration.
- In January 2024, ELITechGroup launched the CE-IVDR certified GI Bacterial PLUS ELITE MGB®Kit, aiming to enhance diagnostics for gastrointestinal bacterial infections. This assay targets key pathogens like Campylobacter spp., Clostridium difficile, Salmonella spp., Shigella spp., and Yersinia enterocolitica, which are linked to food and waterborne infections. The certification emphasizes quality, and the kit is validated for use with ELITe InGenius and ELITe BeGenius instruments. Further, ELITechGroup plans to release three additional kits for parasitic and viral gastrointestinal infections, expanding its diagnostic offerings and commitment to managing severe gastrointestinal conditions.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global in-vitro diagnostics (IVD) market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global In-Vitro Diagnostics (IVD) Market Sales Analysis – Application | Product | Technology | End-User ($ Million)
- In-Vitro Diagnostics (IVD) Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key In-Vitro Diagnostics (IVD) Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Global In-Vitro Diagnostics (IVD) Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global In-Vitro Diagnostics (IVD) Market: Impact Analysis
- Market Opportunities
- Opportunities For Global In-Vitro Diagnostics (IVD) Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – In-Vitro Diagnostics (IVD) Market Revenue and Share by Manufacturers
- In-Vitro Diagnostics (IVD) Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Danaher Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hoffmann-La Roche Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories
- Key Company Analysis
- Global In-Vitro Diagnostics (IVD) Market Sales Analysis by Application ($ Million)
- Diabetes
- Infectious Diseases
- Cancer
- Drug Testing
- Autoimmune Diseases
- Others
- Global In-Vitro Diagnostics (IVD) Market Sales Analysis by Product ($ Million)
- Instruments
- Reagents
- Software and Services
- Global In-Vitro Diagnostics (IVD) Market Sales Analysis by Technology ($ Million)
- Immunodiagnostics
- Molecular Diagnostics
- Hematology
- Tissue Diagnostics
- Others
- Global In-Vitro Diagnostics (IVD) Market Sales Analysis by End-User ($ Million)
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- Regional Analysis
- North American In-Vitro Diagnostics (IVD) Market Sales Analysis – Application | Product | Technology | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European In-Vitro Diagnostics (IVD) Market Sales Analysis – Application | Product | Technology | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific In-Vitro Diagnostics (IVD) Market Sales Analysis – Application | Product | Technology | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World In-Vitro Diagnostics (IVD) Market Sales Analysis – Application | Product | Technology | End-User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Agilent Technologies
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company (BD)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- bioMérieux
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cepheid / Danaher
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- DiaSorin S.p.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hologic, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Luminex
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ortho Clinical Diagnostics / QuidelOrtho Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Qiagen N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Quest Diagnostics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Roche Diagnostics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sysmex Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global In-Vitro Diagnostics (IVD) Market Research and Analysis by Application, 2025–2035 ($ Million)
2. Global In-Vitro Diagnostics (IVD) In Diabetes Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global In-Vitro Diagnostics (IVD) In Infectious Diseases Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global In-Vitro Diagnostics (IVD) In Cancer Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global In-Vitro Diagnostics (IVD) In Drug Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global In-Vitro Diagnostics (IVD) In Autoimmune Diseases Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global In-Vitro Diagnostics (IVD) In Other Application Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global In-Vitro Diagnostics (IVD) Market Research and Analysis by Product, 2025–2035 ($ Million)
9. Global Instruments In-Vitro Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Reagents In-Vitro Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Software and Services In-Vitro Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global In-Vitro Diagnostics (IVD) Market Research and Analysis by Technology, 2025–2035 ($ Million)
13. Global In-Vitro Immunodiagnostics Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global In-Vitro Molecular Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global In-Vitro Hematology Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global In-Vitro Tissue Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global In-Vitro Other Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global In-Vitro Diagnostics (IVD) Market Research and Analysis by End-User, 2025–2035 ($ Million)
19. Global In-Vitro Diagnostics (IVD) For Hospitals & Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
20. Global In-Vitro Diagnostics (IVD) For Diagnostic Laboratories Market Research and Analysis by Region, 2025–2035 ($ Million)
21. Global In-Vitro Diagnostics (IVD) For Other End User Market Research and Analysis by Region, 2025–2035 ($ Million)
22. Global In-Vitro Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
23. North American In-Vitro Diagnostics (IVD) Market Research and Analysis by Country, 2025–2035 ($ Million)
24. North American In-Vitro Diagnostics (IVD) Market Research and Analysis by Application, 2025–2035 ($ Million)
25. North American In-Vitro Diagnostics (IVD) Market Research and Analysis by Product, 2025–2035 ($ Million)
26. North American In-Vitro Diagnostics (IVD) Market Research and Analysis by Technology, 2025–2035 ($ Million)
27. North American In-Vitro Diagnostics (IVD) Market Research and Analysis by End-User, 2025–2035 ($ Million)
28. European In-Vitro Diagnostics (IVD) Market Research and Analysis by Country, 2025–2035 ($ Million)
29. European In-Vitro Diagnostics (IVD) Market Research and Analysis by Application, 2025–2035 ($ Million)
30. European In-Vitro Diagnostics (IVD) Market Research and Analysis by Product, 2025–2035 ($ Million)
31. European In-Vitro Diagnostics (IVD) Market Research and Analysis by Technology, 2025–2035 ($ Million)
32. European In-Vitro Diagnostics (IVD) Market Research and Analysis by End-User, 2025–2035 ($ Million)
33. Asia-Pacific In-Vitro Diagnostics (IVD) Market Research and Analysis by Country, 2025–2035 ($ Million)
34. Asia-Pacific In-Vitro Diagnostics (IVD) Market Research and Analysis by Application, 2025–2035 ($ Million)
35. Asia-Pacific In-Vitro Diagnostics (IVD) Market Research and Analysis by Product, 2025–2035 ($ Million)
36. Asia-Pacific In-Vitro Diagnostics (IVD) Market Research and Analysis by Technology, 2025–2035 ($ Million)
37. Asia-Pacific In-Vitro Diagnostics (IVD) Market Research and Analysis by End-User, 2025–2035 ($ Million)
38. Rest of the World In-Vitro Diagnostics (IVD) Market Research and Analysis by Region, 2025–2035 ($ Million)
39. Rest of the World In-Vitro Diagnostics (IVD) Market Research and Analysis by Application, 2025–2035 ($ Million)
40. Rest of the World In-Vitro Diagnostics (IVD) Market Research and Analysis by Product, 2025–2035 ($ Million)
41. Rest of the World In-Vitro Diagnostics (IVD) Market Research and Analysis by Technology, 2025–2035 ($ Million)
42. Rest of the World In-Vitro Diagnostics (IVD) Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global In-Vitro Diagnostics (IVD) Market Share by Application, 2025 vs 2035 (%)
2. Global In-Vitro Diagnostics (IVD) in Diabetes Market Share by Region, 2025 vs 2035 (%)
3. Global In-Vitro Diagnostics (IVD) in Infectious Diseases Market Share by Region, 2025 vs 2035 (%)
4. Global In-Vitro Diagnostics (IVD) in Cancer Market Share by Region, 2025 vs 2035 (%)
5. Global In-Vitro Diagnostics (IVD) in Drug Testing Market Share by Region, 2025 vs 2035 (%)
6. Global In-Vitro Diagnostics (IVD) in Autoimmune Diseases Market Share by Region, 2025 vs 2035 (%)
7. Global In-Vitro Diagnostics (IVD) in Other Applications Market Share by Region, 2025 vs 2035 (%)
8. Global In-Vitro Diagnostics (IVD) Market Share by Product, 2025 vs 2035 (%)
9. Global Instruments In-Vitro Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
10. Global Reagents In-Vitro Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
11. Global Software and Services In-Vitro Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
12. Global In-Vitro Diagnostics (IVD) Market Share by Technology, 2025 vs 2035 (%)
13. Global In-Vitro Immunodiagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
14. Global In-Vitro Molecular Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
15. Global In-Vitro Hematology Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
16. Global In-Vitro Tissue Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
17. Global In-Vitro Other Diagnostics (IVD) Market Share by Region, 2025 vs 2035 (%)
18. Global In-Vitro Diagnostics (IVD) Market Share by End-User, 2025 vs 2035 (%)
19. Global In-Vitro Diagnostics (IVD) for Hospitals & Clinics Market Share by Region, 2025 vs 2035 (%)
20. Global In-Vitro Diagnostics (IVD) for Diagnostic Laboratories Market Share by Region, 2025 vs 2035 (%)
21. Global In-Vitro Diagnostics (IVD) for Other End-User Market Share by Region, 2025 vs 2035 (%)
22. Global In-Vitro Diagnostics (IVD) Market Share by Region, 2025 Vs 2035 (%)
23. US In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
24. Canada In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
25. UK In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
26. France In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
27. Germany In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
28. Italy In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
29. Spain In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
30. Russia In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
31. Rest of Europe In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
32. India In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
33. China In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
34. Japan In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
35. South Korea In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
36. Australia and New Zealand In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
37. ASEAN Economies In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
38. Rest of Asia-Pacific In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
39. Latin America In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
40. Middle East and Africa In-Vitro Diagnostics (IVD) Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the In-Vitro Diagnostics Market in 2025 is estimated to be around $108.3 billion.
North America holds the largest share in the global In-Vitro Diagnostics (IVD) market.
Leading players in the In-Vitro Diagnostics Market include BAE Systems plc, General Dynamics Corp., Northrop Grumman Corp., Olin Corp., Rheinmetall AG, among others.
In-Vitro Diagnostics Market is expected to grow at a CAGR of 5.7% from 2026 to 2035.
The In-Vitro Diagnostics market is growing due to rising chronic and infectious diseases, increasing demand for early and accurate diagnosis, technological advancements, and expanding geriatric population.
